Allscripts Healthcare Solutions Inc (MDRX) Solutions: Worth A Shot? – Cerner Corporation (CERN)

Page 1 of 2

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has been through a pretty rough patch. The company, which makes electronic medical record software for large healthcare organizations, has seen turmoil and turnover on its board of directors, the departure of its CEO, a stinging rebuke from major shareholders, and the possibility of throwing in the towel and selling out.

Not surprisingly, the tech vendor, which has a market cap of $1.8 billion, has seen its stock price plummet, losing 48 percent of its value over the last year. That’s something of a trick in an era when hospitals are rewarded handsomely by the government for buying EMRs, courtesy of federal legislation allocating billions in incentive bucks.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)

Compare that to a competitor like  Cerner Corporation (NASDAQ:CERN), and you get a picture of just what kind of market seems to be passing Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by. Cerner Corporation (NASDAQ:CERN), which closed at $92.29 per share on March 8, has climbed from a 52-week low of $67.64 per share. Cerner Corporation (NASDAQ:CERN) has a $15.89 billion market cap, and last reported EPS of $2.26. Given its market-leading position as a vendor to hospitals, I don’t think it’s peaked yet either.

OK, so maybe it hasn’t played its hand well of late, but Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) hasn’t lost all of its fans. In fact, the high-performing Vanguard Health Fund made Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) one of its biggest investments of the year in 2012, picking up 3.8 million shares at about $12 per share. (So far, the investment is still underwater; Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) closed at $11.22 per share on February 13, still in the ballpark, but not an improvement either.)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) rose as high as $22 per share during the past 52 weeks, so there’s reason for hope for any investor that gets in now. The question is just how much hope, given the still-stormy seas Allscripts rides on these days. Let’s break it down.

In Allscripts’ favor:

* Steady growth: Over the past five years Allscripts has seen 14.8% annual revenue growth and 19.7% for EBITDA. Free cash flow has grown a striking 82.8 percent, which is nothing to sneeze at.

Strong market position: Despite some questionable moves (such as discontinuing its physician product abruptly) which lost it some respect, Allscripts remains on the shortlist when hospitals are buying, along with giants like Cerner Corporation (NASDAQ:CERN) and privately-held colossus Epic Systems.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 9 Most Dangerous Countries for Tourists to Visit

Reign of Terror: The 10 Most Ruthless Politicians in History

On the Move: The 10 Fastest Growing Businesses in 2015

Fast Money: The 10 Highest Paying Fast Food Restaurants

Mixing It Up: The 14 Best Music Mashups of 2014

Rito Pls Buff: The 10 Least Played Champions in LoL Season 4

10 Covers of Popular Songs that are Better than the Originals

Must See TV: The 9 Most Anticipated Shows of 2015

The 15 Biggest Box Office Bombs of All Time

10 Things The World Can’t Stand About Americans

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!